Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abbott v. Medtronic

This article was originally published in The Gray Sheet

Executive Summary

Advanced Cardiovascular Solutions, a subsidiary of Abbott Laboratories formerly owned by Guidant, did not commit "inequitable conduct" to obtain stent technology that is also incorporated into Medtronic's S7 and Driver coronary stents, a U.S. District Court in Delaware rules April 24. The ruling completes the liability phase of a patent case originally brought by Guidant against Medtronic Vascular, although Medtronic says it will appeal (1"The Gray Sheet" March 21, 2005, p. 24). Medtronic also says that the decision does not impact the ongoing United States Patent and Trademark Office proceedings on the same patent. The USPTO is reexamining whether Guidant's so-called "Lau patents" are valid in light of Medtronic's claims of "prior art"...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024728

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel